About PGA-OA

Crescent Innovations, Inc. has developed a new treatment for OA utilizing a new material, poly-g-Glutamic Acid (gPGA). This biological polymer has been shown by Crescent Innovations to reduce inflammation as marked by Matrix-Metallo-Protinases (MMPs), the key disease molecular target for OA. Pre-clinical studies have shown gPGA to be significantly more effective than HA for reducing pain. gPGA has passed all GLP safety studies to date and is very close to clinical deployment.